标题
How to manage patients with corticosteroids in oncology in the era of immunotherapy?
作者
关键词
Corticosteroid, Cancer, Immunotherapy, Immune-related adverse event, T-cell lymphocyte
出版物
EUROPEAN JOURNAL OF CANCER
Volume 141, Issue -, Pages 239-251
出版商
Elsevier BV
发表日期
2020-11-16
DOI
10.1016/j.ejca.2020.09.032
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of anti-TNF with decreased survival in steroid refractory ipilimumab and anti-PD1 treated patients in the Dutch Melanoma Treatment Registry
- (2020) Rik J. Verheijden et al. CLINICAL CANCER RESEARCH
- A Case of Response to Immunotherapy in a Patient With MSI Metastatic Colorectal Cancer and Autoimmune Disease in Steroid Therapy
- (2020) Maria Massucci et al. JOURNAL OF IMMUNOTHERAPY
- Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo
- (2020) Alexander M. M. Eggermont et al. JAMA Oncology
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study
- (2020) Jean-Marie Michot et al. EUROPEAN JOURNAL OF CANCER
- Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
- (2020) J. Haanen et al. ANNALS OF ONCOLOGY
- Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) John A. Thompson et al. Journal of the National Comprehensive Cancer Network
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities
- (2019) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- T Cell Dysfunction in Cancer Immunity and Immunotherapy
- (2019) Anliang Xia et al. Frontiers in Immunology
- Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
- (2019) Cindy Strehl et al. Frontiers in Immunology
- Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications
- (2019) Biagio Ricciuti et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Preexisting Autoimmune Disease: A Nationwide Multicenter Cohort Study
- (2019) Alice Tison et al. Arthritis & Rheumatology
- 55P Incidence and clinical implications of late immune-related adverse events in long responders to PD-1/PD-L1 checkpoint inhibitors: A multicenter study
- (2019) O Nigro et al. ANNALS OF ONCOLOGY
- 46O Impact of early introduction of steroid on immune-checkpoint inhibitors (ICI) in patients with advanced non-small cell lung cancer treated
- (2019) A De Giglio et al. ANNALS OF ONCOLOGY
- Toxicities and outcomes: Do steroids matter?
- (2018) Douglas B. Johnson CANCER
- High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma
- (2018) Alexander T. Faje et al. CANCER
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Brief report: Early use of systemic corticosteroids in patients with advanced NSCLC treated with nivolumab
- (2018) Susan Combs Scott et al. Journal of Thoracic Oncology
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience
- (2018) Michael D. Richter et al. Arthritis & Rheumatology
- Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
- (2018) Amber J. Giles et al. Journal for ImmunoTherapy of Cancer
- Consequences of long-term OCS therapy and its side effects in severe asthma in adults – A focused review of the impact data in the literature
- (2018) Timm Volmer et al. EUROPEAN RESPIRATORY JOURNAL
- Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer
- (2018) Kathryn C. Arbour et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical management of spinal metastases—The Dutch national guideline
- (2018) Laurens Bollen et al. EUROPEAN JOURNAL OF CANCER
- Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs
- (2018) Arianna Draghi et al. INTERNATIONAL JOURNAL OF CANCER
- Non-genomic Effects of Glucocorticoids: An Updated View
- (2018) Reynold A. Panettieri et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
- (2018) Cheng Xu et al. BMJ-British Medical Journal
- Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience
- (2017) Takeo Fujii et al. INVESTIGATIONAL NEW DRUGS
- Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
- (2017) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention and management of glucocorticoid-induced side effects: A comprehensive review
- (2017) Avrom Caplan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- NCCN Guidelines Insights: Antiemesis, Version 2.2017
- (2017) Michael J. Berger et al. Journal of the National Comprehensive Cancer Network
- NCCN Guidelines Insights: Palliative Care, Version 2.2017
- (2017) Maria Dans et al. Journal of the National Comprehensive Cancer Network
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016
- (2016) Noam VanderWalde et al. Journal of the National Comprehensive Cancer Network
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting
- (2016) Christina H. Ruhlmann et al. SUPPORTIVE CARE IN CANCER
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Effects of Systemically Administered Hydrocortisone on the Human Immunome
- (2016) Matthew J. Olnes et al. Scientific Reports
- Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
- (2015) S. Champiat et al. ANNALS OF ONCOLOGY
- Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy
- (2015) Kailin Xing et al. BMC IMMUNOLOGY
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
- (2015) Troy Z. Horvat et al. JOURNAL OF CLINICAL ONCOLOGY
- Central Nervous System Cancers, Version 1.2015
- (2015) Louis Burt Nabors et al. Journal of the National Comprehensive Cancer Network
- Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial
- (2015) Edward Chow et al. LANCET ONCOLOGY
- Review of Clinical Trials of Pharmacologic Interventions for Cancer-Related Fatigue
- (2014) Sriram Yennurajalingam et al. CANCER JOURNAL
- Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients With Advanced Cancer Using Opioids: A Randomized, Placebo-Controlled, Double-Blind Trial
- (2014) Ørnulf Paulsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
- (2014) R. J. Auchus et al. ONCOLOGIST
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Treatment of Leptomeningeal Spread of NSCLC: A Continuing Challenge
- (2012) Seema Nagpal et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy
- (2010) Kaan Harmankaya et al. MEDICAL ONCOLOGY
- Glucocorticoid-Induced Hyperglycemia
- (2009) John Clore et al. Endocrine Practice
- Antiviral prophylaxis in haematological patients: Systematic review and meta-analysis
- (2009) Dafna Yahav et al. EUROPEAN JOURNAL OF CANCER
- Prevention of strongyloides hyperinfection syndrome: A rheumatological point of view
- (2009) Mittermayer Santiago et al. European Journal of Internal Medicine
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Timothy C. Ryken et al. JOURNAL OF NEURO-ONCOLOGY
- The use and toxicity of steroids in the management of patients with brain metastases
- (2008) Alina Sturdza et al. SUPPORTIVE CARE IN CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now